about
Failure to detect the novel retrovirus XMRV in chronic fatigue syndromeMouse DNA contamination in human tissue tested for XMRVInvestigation into the presence of and serological response to XMRV in CFS patientsIdentification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus researchFunctional and structural characterization of the integrase from the prototype foamy virusFailure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infectionsPhylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants.Getting the measure of syphilis: qPCR to better understand early infectionDNA extraction columns contaminated with murine sequences.Short-course antiretroviral therapy in primary HIV infection.Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection.Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1.Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infectionChlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NFκB activation resulting in a microenvironment predisposed to ectopic pregnancyPredicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.Clinical outcomes of a combined HIV and renal clinic.No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population.Ubiquitin-dependent virus particle budding without viral protein ubiquitinationDendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognitionInhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vectorHLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infectionPgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.Progress and prospects: foamy virus vectors enter a new age.HIV-1 does not significantly influence Chlamydia trachomatis serovar L2 replication in vitro.Antibodies to Chlamydia trachomatis heat-shock protein 60 kDa and detection of Mycoplasma genitalium and ureaplasma urealyticum are associated independently with chronic nongonococcal urethritis.Identification of sites that act together to direct dimerization of human foamy virus RNA in vitro.Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters.Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packagingThe R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expressionA one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants.Knockdown of mouse VCAM-1 by vector-based siRNA.Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.Identification of domains in gag important for prototypic foamy virus egress.Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.Chronic fatigue syndrome: xenotropic murine leukemia virus-related virus, murine leukemia virus, both, or neither?
P50
Q21090038-81422BC1-A105-4F13-A80B-E27BBD0F6ADDQ21093226-01434365-25E7-4244-A147-B879F45DB817Q21560846-FA47E844-230E-4B77-848C-16837B77A5F8Q24651042-40928363-19AA-432B-98DE-4C5CCA682E03Q27653000-4D132ADA-142F-4BAA-AA4D-F3783957573AQ28295313-1EF9C823-FE4A-44F9-95C0-53E338715B56Q30404569-B7E8F864-FB50-4ED9-83FB-17FF0ED2568CQ33960062-8BBB3334-47E9-494D-BD2F-49E768037F91Q34005477-5054DE2A-B003-4F27-9559-C3BE9D86402BQ34037516-5ED036ED-D37E-405B-867E-E063D210374CQ34109778-9B118CA1-CEBF-45C2-BA92-B1C632EC2295Q34239109-5B80CB02-5698-4147-81C1-E0E19E64FEBEQ34252835-74689F69-C5DD-4885-9AAD-DC7CF336CFCAQ34405543-9EB5EEF9-E676-4305-BC1A-1DD3E85916B6Q34469192-74A6EF9B-4E99-447D-8F28-B5A5018EA5B0Q34983860-590C592C-56FA-417C-965D-8B8480CAD483Q35036284-C0311D8D-6496-4339-819F-BAF5ACDF2F69Q35453074-6C3A49E1-072D-48A9-8CAF-1F74E2E30610Q35692351-1FBB87B2-99D9-416B-A302-3ABE41F9FFF2Q36289026-E51EFFE7-84F4-496F-8030-8ABFD062D775Q36736399-D6F5D04D-20AA-4CAD-BBC7-312BC7D22D66Q36890686-A4066816-6894-426B-AD73-4C0B29B3F858Q37051649-EA678DF0-98D5-4FB4-8DF0-1B6B40BF71E2Q37213912-ADC32663-30D4-4247-AEB6-DAD2D79B5C06Q37772765-C646F835-A501-4709-AA8A-73B09FEA087FQ37851385-727F6C0E-E254-4936-9690-8DC4AEFE4631Q37870236-174B6908-A5F0-4BC1-983E-B0ABE4994D8DQ38347886-9E622711-F4F0-4DF4-8760-0929B03BF88BQ38398452-CC2C3888-7398-4FF5-9C32-68FC2164C606Q38423867-C4F6C78E-CE00-4CFE-A62C-84A97B421725Q39043245-CFF64DAD-D3AF-47B0-936A-927FAD205CD3Q39590160-D645CD8C-CABF-4FCF-9A25-2D7BDEFA838CQ39603688-815B48B6-EC88-4163-A9EA-495D477BD210Q39914006-5B08F7A8-7C38-4571-BB31-2E37357B0E03Q40202408-6CD9C8BE-3E90-4593-A4F2-6422844CFE16Q40315535-1694CDAA-D529-4E63-9FD7-A3A41CD3F2CEQ40413098-8E133137-EF57-411F-9FB7-8665D45317F6Q40429737-AFD282A9-BF53-436D-A6CF-90648C7DC8C0Q40448653-9AB49F40-9DB7-48F5-AE57-6F8ED097C9D3Q42381736-FA9BF355-83F2-4662-9C34-73369830A390
P50
description
researcher ORCID ID = 0000-0002-5494-407X
@en
wetenschapper
@nl
name
Myra McClure
@ast
Myra McClure
@en
Myra McClure
@es
Myra McClure
@nl
type
label
Myra McClure
@ast
Myra McClure
@en
Myra McClure
@es
Myra McClure
@nl
prefLabel
Myra McClure
@ast
Myra McClure
@en
Myra McClure
@es
Myra McClure
@nl
P106
P21
P31
P496
0000-0002-5494-407X